|Other Names||Clarin-1, Usher syndrome type-3 protein, CLRN1, USH3A|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP7339b was selected from the C-term region of human CLRN1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May have a role in the excitatory ribbon synapse junctions between hair cells and cochlear ganglion cells and presumably also in analogous synapses within the retina.|
|Cellular Location||Membrane; Multi-pass membrane protein|
|Tissue Location||Widely expressed. Found in the retina.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CLRN1 is a protein that contains a cytosolic N-terminus, multiple helical transmembrane domains, and an endoplasmic reticulum membrane retention signal, TKGH, in the C-terminus. The protein may be important in development and homeostasis of the inner ear and retina.
Herrera,W., Aleman,T.S. Invest. Ophthalmol. Vis. Sci. 49 (6), 2651-2660 (2008)Aller,E., Jaijo,T. Clin. Genet. 66 (6), 525-529 (2004)Joensuu,T., Hamalainen,R. Genomics 63 (3), 409-416 (2000)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.